Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
No REMS Required: Aduhelm’s ARIA Risks, MRI Guidance Conveyed In Labeling, Voluntary Communications
Aug 19 2021
•
By
Sue Sutter
Labeling is sufficient for conveying the ARIA risk with Aduhelm, the FDA concluded. • Source: Alamy
More from Product Reviews
More from Pink Sheet